Clinical trial
An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of…
NCT00492323 · SK Life Science, Inc., Industry · Completed
Key facts
| NCT number | NCT00492323 |
|---|---|
| Title | An Effectiveness and Safety Study With RWJ-333369 (Carisbamate) for the Study of Postherpetic Neuralgia (PHN). |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group With a Crossover Confirmation Period Study of RWJ-333369 for the Treatment of Postherpetic Neuralgia. |
| Lead sponsor | SK Life Science, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postherpetic Neuralgia, Neuralgia, Herpes Zoster |
| Intervention type | Drug |
| Interventions | placebo, carisbamate |
| Enrollment | 91 |
| Start date | Mar 1, 2007 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | May 1, 2018 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: